Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
elliquence is a private medical device company focused on minimally invasive and endoscopic spine, neurosurgery, orthopedic, pain management, and interventional radiology procedures. The company builds and markets radiofrequency-enabled surgical systems, endoscopic spine platforms, drills, and procedural instruments designed to preserve healthy tissue and reduce surgical trauma. Its portfolio includes the Disc-FX discectomy system, the Trigger-Flex directional RF handpiece, the Surgi-Max platform, and endoscopic spine systems such as Mult-e Portal. elliquence also supports physician adoption through clinical education and procedural training. The business appears to be commercially active and operating as part of parent company KMC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on elliquence.